The Informulary method extracts data from publicly available Food & Drug Administration (FDA) reviews written during the drug approval process – and from high-quality systematic reviews – to highlight the benefits, side effects and uncertainties of prescription drugs. Our expert team - which includes doctors, pharmacists, public health specialists, medical librarians - examine the data and work with experienced entrepreneurs to produce the DrugFactsBox™ - a highly accessible, comprehensive summary.
Drs. Steven Woloshin and Lisa Schwartz are an internationally known research team in risk communication. They are general internists and professors of medicine at Dartmouth Medical School and co-directors of the Center for Medicine in the Media at The Dartmouth Institute for Health Policy and Clinical Practice. They have consulted for the FDA, Institute of Medicine, National Institutes of Health, National Cancer Institute, US Preventive Services Task Force, and ClinicalTrials.gov. They are co-authors of two books, Know Your Chances and Overdiagnosed, and their essays have appeared in the New York Times, Washington Post, and Los Angeles Times.
The effectiveness of the DrugFactsBox™ to improve understanding of what drugs can and can’t do has been documented in nearly two decades of research published in leading journals including the Annals of Internal Medicine, the New England Journal of Medicine, the Proceedings of the National Academy of Sciences and the British Medical Journal. The FDA's Risk Communication Advisory Committee recommended adopting the DrugFactsBox™ format as a standard for all drug information, and it was included in section 3507 of the Affordable Care Act.
We’re a for-profit company with non-profit ethics. The DrugFactsBox™ is a truly independent, unbiased source of drug information. So we don’t take money from pharma – or anti-pharma – organizations. Period.